Dr Adam Ritchie

Bioreactors and the art of manufacturing a Covid vaccine

When Covid struck and the quest for a vaccine began, the team at Oxford had a head start in that we were already working with the harmless common cold virus on which the AstraZeneca vaccine is based. ChAdOx — a contraction of ‘chimpanzee’, from which the virus was isolated, ‘adenovirus’ and ‘Oxford’ — is also being used to target diseases such as malaria, rabies, zika and Mers.

Already a subscriber? Log in

Keep reading with a free trial

Subscribe and get your first month of online and app access for free. After that it’s just £1 a week.

There’s no commitment, you can cancel any time.


Unlock more articles


Written by
Dr Adam Ritchie
Dr Adam Ritchie is a scientist specialising in vaccine development. He is currently focused on the Covid-19 and rabies vaccine projects at the University of Oxford.

Topics in this article


Don't miss out

Join the conversation with other Spectator readers. Subscribe to leave a comment.

Already a subscriber? Log in